XML 22 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Restricted Stock Units
Common Stock
Common Stock
Restricted Stock Units
Additional Paid-in Capital
Additional Paid-in Capital
Restricted Stock Units
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Loss
Non-controlling interest in consolidated subsidiaries
Balance, beginning of period (in shares) at Dec. 31, 2020     56,108         20    
Balance, beginning of period at Dec. 31, 2020 $ 1,983,018   $ 56   $ 660,771   $ 1,347,880 $ (177) $ (25,512) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Restricted stock units vested (in shares)       248            
Restricted stock units withheld for employee taxes (in shares)       (84)            
Units withheld for employee taxes   $ (31,935)       $ (31,935)        
Stock-based compensation expense 14,624       14,624          
Proceeds from stock options exercises (in shares)     109              
Exercise of stock options 4,424   $ 0   4,424          
Other comprehensive loss (15,238)               (15,238)  
Net income 109,046           109,046      
Balance, end of period (in shares) at Mar. 31, 2021     56,381         20    
Balance, end of period at Mar. 31, 2021 $ 2,063,939   $ 56   647,884   1,456,926 $ (177) (40,750) 0
Balance, beginning of period (in shares) at Dec. 31, 2021 56,849   56,849         20    
Balance, beginning of period at Dec. 31, 2021 $ 2,495,837   $ 57   711,912   1,829,532 $ (177) (54,207) 8,720
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Restricted stock units vested (in shares)       193            
Restricted stock units withheld for employee taxes (in shares)       (67)            
Units withheld for employee taxes   $ (18,376)       $ (18,376)        
Stock-based compensation expense 22,702       22,702          
Proceeds from stock options exercises (in shares)     158              
Exercise of stock options 2,884       2,884          
Other comprehensive loss (31,943)               (31,943)  
Purchase of noncontrolling interest (7,067)                 (7,067)
Net income $ 89,719           89,719      
Balance, end of period (in shares) at Mar. 31, 2022 57,133   57,133         20    
Balance, end of period at Mar. 31, 2022 $ 2,553,756   $ 57   $ 719,122   $ 1,919,251 $ (177) $ (86,150) $ 1,653